1. Home
  2. VLRS vs KALV Comparison

VLRS vs KALV Comparison

Compare VLRS & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • KALV
  • Stock Information
  • Founded
  • VLRS 2005
  • KALV N/A
  • Country
  • VLRS Mexico
  • KALV United States
  • Employees
  • VLRS N/A
  • KALV N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • KALV Health Care
  • Exchange
  • VLRS Nasdaq
  • KALV Nasdaq
  • Market Cap
  • VLRS 671.0M
  • KALV 637.9M
  • IPO Year
  • VLRS N/A
  • KALV N/A
  • Fundamental
  • Price
  • VLRS $6.15
  • KALV $15.82
  • Analyst Decision
  • VLRS Buy
  • KALV Strong Buy
  • Analyst Count
  • VLRS 6
  • KALV 9
  • Target Price
  • VLRS $8.18
  • KALV $26.29
  • AVG Volume (30 Days)
  • VLRS 425.7K
  • KALV 734.1K
  • Earning Date
  • VLRS 10-21-2025
  • KALV 09-09-2025
  • Dividend Yield
  • VLRS N/A
  • KALV N/A
  • EPS Growth
  • VLRS N/A
  • KALV N/A
  • EPS
  • VLRS N/A
  • KALV N/A
  • Revenue
  • VLRS $3,019,191,000.00
  • KALV N/A
  • Revenue This Year
  • VLRS N/A
  • KALV N/A
  • Revenue Next Year
  • VLRS $12.17
  • KALV $221.95
  • P/E Ratio
  • VLRS N/A
  • KALV N/A
  • Revenue Growth
  • VLRS N/A
  • KALV N/A
  • 52 Week Low
  • VLRS $3.49
  • KALV $7.30
  • 52 Week High
  • VLRS $9.00
  • KALV $16.32
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 62.42
  • KALV 71.16
  • Support Level
  • VLRS $6.08
  • KALV $13.72
  • Resistance Level
  • VLRS $6.27
  • KALV $13.96
  • Average True Range (ATR)
  • VLRS 0.18
  • KALV 0.69
  • MACD
  • VLRS -0.03
  • KALV 0.31
  • Stochastic Oscillator
  • VLRS 75.00
  • KALV 99.15

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: